相关实验视频
Updated: May 10, 2025

Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
精密药物输送纳米材料的进步:对药物动力学和毒性的洞察
Devika Tripathi1, Prashant Pandey2,3, Sakshi Sharma1
1PSIT-Pranveer Singh Institute of Technology (Pharmacy), Kanpur Uttar Pradesh, 208002, India.
纳米医学利用纳米技术进行先进的药物输送,提高治疗效率和安全性. 患者变异性和复杂的药物配置文件等挑战阻碍了临床使用,但个性化癌症治疗的潜力是巨大的.
科学领域:
- 纳米医学是一种纳米医学.
- 生物技术是生物技术.
- 药物输送系统 药物输送系统
背景情况:
- 传统疗法在有效性,特异性和安全性方面存在局限性.
- 纳米技术的整合提供了先进的药物输送解决方案.
- 纳米级系统旨在优化针对性治疗的药理动力学和生物分布.
研究的目的:
- 分析纳米材料在克服药物输送挑战中的作用.
- 讨论将纳米医学从研究转化为临床实践的障碍.
- 突出纳米医学在个性化癌症治疗中的潜力.
主要方法:
- 对药物输送中的纳米材料进行深入分析.
- 审查临床采用的挑战.
- 探索纳米载体的ADME配置文件.
- 讨论患者异质性和生理变异性.
主要成果:
- 纳米材料通过绕过障碍来增强药物输送,提高生物可用性,并使控制释放成为可能.
- 显著的障碍包括患者异质性,可变的ADME概况,有限的组织透率和不一致的患者反应.
- 需要用于纳米材料表征的标准化协议.
结论:
- 纳米医学具有巨大的潜力,可以彻底改变个性化癌症治疗.
- 克服临床翻译障碍需要增加翻译研究和国际合作.
- 实现纳米医学的全部能力需要解决精密瘤学的当前挑战.
更多相关视频
09:47Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
08:47Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
Published on: September 28, 2022
相关概念视频
Nonlinear Pharmacokinetics: Overview
Nonlinearity can arise due to the saturation of plasma protein-binding or...
Biopharmaceutics and Pharmacokinetics: Overview
Factors Affecting Dissolution: Particle Size and Effective Surface Area
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Nonlinear Pharmacokinetics: Bioavailability and Protein-Drug Binding
To quantify the extent of bioavailability, pharmacologists often use a parameter called .
Pharmacodynamics: Overview and Principles
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...